{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:59:39Z","timestamp":1790488779820,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"School of Public Health, University of Queensland"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12936-015-0919-5","type":"journal-article","created":{"date-parts":[[2015,10,6]],"date-time":"2015-10-06T11:23:27Z","timestamp":1444130607000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["A systematic review of the efficacy of a single dose artemisinin\u2013naphthoquine in treating uncomplicated malaria"],"prefix":"10.1186","volume":"14","author":[{"given":"Cho","family":"Naing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxine A.","family":"Whittaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon Wah","family":"Mak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyan","family":"Aung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,6]]},"reference":[{"key":"919_CR1","volume-title":"Global technical strategy for malaria 2016\u20132030","author":"WHO","year":"2015","unstructured":"WHO. Global technical strategy for malaria 2016\u20132030. Geneva: World Health Organization; 2015."},{"key":"919_CR2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1473-3099(10)70079-7","volume":"10","author":"NM Douglas","year":"2010","unstructured":"Douglas NM, Anstey NM, Angus BJ, Nosten F, Price RN. Artemisinin combination therapy for vivax malaria. Lancet Infect Dis. 2010;10:405\u201316.","journal-title":"Lancet Infect Dis"},{"key":"919_CR3","doi-asserted-by":"crossref","first-page":"947","DOI":"10.4269\/ajtmh.2007.77.947","volume":"77","author":"J Marfurt","year":"2007","unstructured":"Marfurt J, Mueller I, Sie A, Maku P, Goroti M, Reeder JC, et al. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea. Am J Trop Med Hyg. 2007;77:947\u201354.","journal-title":"Am J Trop Med Hyg"},{"key":"919_CR4","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S1473-3099(02)00372-9","volume":"2","author":"PJ Guerin","year":"2002","unstructured":"Guerin PJ, Olliaro P, Nosten F, Druilhe P, Laxminarayan R, Binka F, et al. Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development. Lancet Infect Dis. 2002;2:564\u201373.","journal-title":"Lancet Infect Dis"},{"key":"919_CR5","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1172\/JCI21682","volume":"113","author":"N White","year":"2004","unstructured":"White N. Antimalarial drug resistance. J Clin Invest. 2004;113:1084\u201392.","journal-title":"J Clin Invest"},{"key":"919_CR6","first-page":"131","volume":"21","author":"JY Wang","year":"2003","unstructured":"Wang JY, Shan CQ, Fu DD, Sun ZW, Ding DB. Efficacy of naphthoquine, artemisinine and a combination of the two drugs in the treatment of falciparum malaria. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2003;21:131\u20133.","journal-title":"Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi."},{"key":"919_CR7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.actatropica.2003.11.008","volume":"89","author":"JY Wang","year":"2004","unstructured":"Wang JY, Cao WC, Shan CQ, Zhang M, Li GF, Ding DB, et al. Naphthoquine phosphate and its combination with artemisinine. Acta Trop. 2004;89:375\u201381.","journal-title":"Acta Trop"},{"key":"919_CR8","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/1475-2875-8-200","volume":"8","author":"K Stepniewska","year":"2009","unstructured":"Stepniewska K, Taylor W, Sirima SB, Ouedraogo EB, Ouedraogo A, Gansane A, et al. Population pharmacokinetics of artesunate and amodiaquine in African children. Malar J. 2009;8:200.","journal-title":"Malar J"},{"key":"919_CR9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1586\/ecp.12.40","volume":"5","author":"R Liu","year":"2012","unstructured":"Liu R, Dong HF, Jiang MS. A pharmacokinetic approach to assess artemisinin\u2013naphthoquine combination therapy for uncomplicated pediatric malaria. Expert Rev Clin Pharmacol. 2012;5:521\u20134.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"919_CR10","first-page":"1","volume":"3","author":"BM Nour","year":"2014","unstructured":"Nour BM, Hamed MN, Habour AB, Elkariem AA, Mohamedani AA, Saeed KO, et al. Efficacy and safety of artemisinin- naphthoquine (ARCO\u00ae) in the treatment of uncomplicated Plasmodium falciparum among Sudanese adults. Global Adv Res J Med Med Sci. 2014;3:1\u20137.","journal-title":"Global Adv Res J Med Med Sci"},{"key":"919_CR11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.actatropica.2009.05.007","volume":"111","author":"T Tun","year":"2009","unstructured":"Tun T, Tint HS, Lin K, Kywa TT, Myint MK, Khaing W, et al. Efficacy of oral single dose therapy with artemisinin\u2013naphthoquine phosphate in uncomplicated falciparum malaria. Acta Trop. 2009;111:275\u20138.","journal-title":"Acta Trop"},{"key":"919_CR12","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1177\/0091270009356296","volume":"50","author":"HY Qu","year":"2010","unstructured":"Qu HY, Gao HZ, Hao GT, Li YY, Li HY, Hu JC, et al. Single-dose safety, pharmacokinetics, and food effects studies of compound naphthoquine phosphate tablets in healthy volunteers. J Clin Pharmacol. 2010;50:1310\u20138.","journal-title":"J Clin Pharmacol"},{"key":"919_CR13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4269\/ajtmh.2004.70.128","volume":"70","author":"K Rath","year":"2004","unstructured":"Rath K, Taxis K, Walz G, Gleiter CH, Li SM, Heide L. Pharmacokinetic study of artemisinin after oral intake of a traditional preparation of Artemisia annua L. (annual wormwood). Am J Trop Med Hyg. 2004;70:128\u201332.","journal-title":"Am J Trop Med Hyg"},{"key":"919_CR14","doi-asserted-by":"crossref","first-page":"807","DOI":"10.2471\/BLT.09.072397","volume":"88","author":"I Carneiro","year":"2010","unstructured":"Carneiro I, Smith L, Ross A, Roca-Feltrer A, Greenwood B, Schellenberg JA, et al. Intermittent preventive treatment for malaria in infants: a decision-support tool for sub-Saharan Africa. Bull World Health Org. 2010;88:807\u201311.","journal-title":"Bull World Health Org"},{"key":"919_CR15","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","volume":"8","author":"D Moher","year":"2010","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8:336\u201341.","journal-title":"Int J Surg."},{"key":"919_CR16","unstructured":"Higgins JPT, Green S (editors). Cochrane handbook for systematic reviews of interventions version 5.1.0 (updated March 2011). The Cochrane Collaboration; 2011."},{"key":"919_CR17","unstructured":"The Cochrane Collaboration. Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen: The Nordic Cochrane Centre; 2014."},{"key":"919_CR18","unstructured":"PROSPERO (International prospective register of systematic reviews). Efficacy and safety of a fixed-dose artemisinin\u2013naphthoquine in treating uncomplicated malaria in treating uncomplicated malaria: a systematic review and meta-analysis. CRD42014009000. 2014."},{"key":"919_CR19","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/1475-2875-8-196","volume":"8","author":"FW Hombhanje","year":"2009","unstructured":"Hombhanje FW, Linge D, Saweri A, Kuanch C, Jones R, Toraso S, et al. Artemisinin\u2013naphthoquine combination (ARCO\u2122) therapy for uncomplicated falciparum malaria in adults of Papua New Guinea: a preliminary report on safety and efficacy. Malar J. 2009;8:196.","journal-title":"Malar J"},{"key":"919_CR20","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1016\/j.ijid.2010.02.2232","volume":"14","author":"J Rujumba","year":"2010","unstructured":"Rujumba J, Mworozi EA, Manganda AK, Kiguba R, Rwakimali B, Nsobya S, et al. A comparative study of Arco and Coartem in the treatment of uncomplicated malaria in patients aged 4\u00a0months to 16\u00a0years attending Mulago hospital, Kampala, Uganda. Int J Infect Dis. 2010;14:e332.","journal-title":"Int J Infect Dis"},{"key":"919_CR21","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s13149-012-0211-7","volume":"105","author":"D Kinde-Gazard","year":"2012","unstructured":"Kinde-Gazard D, Ogouyemi-Hounto A, Capo-Chichi L, Gbaguidi J, Massougbodji A. A randomized clinical trial comparing the effectiveness and tolerability of artemisinine-naphthoquine (Arco\u00ae) and artemether\u2013lumefantrine (Coartem\u00ae) in the treatment of uncomplicated malaria in Benin (in French). Bull Soc Pathol Exot. 2012;105:208\u201314.","journal-title":"Bull Soc Pathol Exot"},{"key":"919_CR22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1475-2875-11-153","volume":"11","author":"E Tjitra","year":"2012","unstructured":"Tjitra E, Hasugian AR, Siswantoro H, Prasetyorini B, Ekowatiningsih R, Yusnita EA, et al. Efficacy and safety of artemisinin\u2013naphthoquine versus dihydroartemisinin\u2013piperaquine in adult patients with uncomplicated malaria: a multi-centre study in Indonesia. Malar J. 2012;11:153.","journal-title":"Malar J"},{"key":"919_CR23","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4314\/njp.v41i3.3","volume":"41","author":"E Udoh","year":"2014","unstructured":"Udoh E, Meremikwu M, Odey F, Oringanje C, Oduwole O, Oyo-ita A. Artemisinin\u2013naphthoquine versus artemether\u2013lumefantrine for treating uncomplicated Plasomodium falciparum malaria in children: a randomized controlled trial of efficacy and safety. Niger J Paediatr. 2014;41:170\u20134.","journal-title":"Niger J Paediatr"},{"key":"919_CR24","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.3390\/ph3123581","volume":"3","author":"FW Hombhanje","year":"2010","unstructured":"Hombhanje FW, Huang Q. Artemisinin\u2013naphthoquine combination (ARCO): an overview of progress. Pharmaceuticals. 2010;3:3581\u201393.","journal-title":"Pharmaceuticals"},{"key":"919_CR25","first-page":"21","volume":"34","author":"S Krudsood","year":"2003","unstructured":"Krudsood S, Chalermrut K, Pengruksa C, Srivilairit S, Silachamroon U, Treeprasertsuk S, et al. Comparative clinical trial of two-fixed combinations dihydroartemisinin-napthoquine-trimethoprim (DNP) and artemether\u2013lumefantrine (Coartem\/Riamet) in the treatment of acute uncomplicated falciparum malaria in Thailand. Southeast Asian J Trop Med Public Health. 2003;34:21\u20136.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"919_CR26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1186\/1475-2875-12-409","volume":"11","author":"H Liu","year":"2013","unstructured":"Liu H, Yang HL, Xu JW, Wang JZ, Nie RH, Li CF. Artemisinin\u2013naphthoquine combination versus chloroquine-primaquine to treat vivax malaria: an open-label randomized and non-inferiority trial in Yunnan Province, China. Malar J. 2013;11:409.","journal-title":"Malar J"},{"key":"919_CR27","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/1475-2875-8-148","volume":"8","author":"OA Toure","year":"2009","unstructured":"Toure OA, Penali LK, Yapi JD, Ako BA, Toure W, Djerea K, et al. A comparative, randomized clinical trial of artemisinin\/naphtoquine twice daily one day versus artemether\/lumefantrine six doses regimen in children and adults with uncomplicated falciparum malaria in C\u00f4te d\u2019Ivoire. Malar J. 2009;8:148.","journal-title":"Malar J"},{"key":"919_CR28","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1128\/AAC.06248-11","volume":"56","author":"J Benjamin","year":"2012","unstructured":"Benjamin J, Moore B, Lee ST, Senn M, Griffin S, Lautu D, et al. Artemisinin\u2013naphthoquine combination therapy for uncomplicated pediatric malaria: a tolerability, safety, and preliminary efficacy study. Antimicrob Agents Chemother. 2012;56:2465\u201371.","journal-title":"Antimicrob Agents Chemother"},{"key":"919_CR29","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1186\/1475-2875-11-413","volume":"11","author":"MM Meremikwu","year":"2012","unstructured":"Meremikwu MM, Odey F, Oringanje C, Oyo-Ita A, Effa E, Esu FB, et al. Open-label trial of three dosage regimens of fixed-dose combination of artemisinin and naphthoquine for treating uncomplicated falciparum malaria in Calabar, Nigeria. Malar J. 2012;11:413.","journal-title":"Malar J"},{"key":"919_CR30","first-page":"CD011547","volume":"2","author":"R Isba","year":"2015","unstructured":"Isba R, Zani B, Gathu M, Sinclair D. Artemisinin\u2013naphthoquine for treating uncomplicated Plasmodium falciparum malaria. Cochrane Database Syst Rev. 2015;2:CD011547.","journal-title":"Cochrane Database Syst Rev."},{"key":"919_CR31","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1128\/AAC.06250-11","volume":"56","author":"KT Batty","year":"2012","unstructured":"Batty KT, Salman S, Moore BR, Benjamin J, Lee ST, Page-Sharp M, et al. Artemisinin\u2013naphthoquine combination therapy for uncomplicated pediatric malaria: a pharmacokinetic study. Antimicrob Agents Chemother. 2012;56:2472\u201384.","journal-title":"Antimicrob Agents Chemother"},{"key":"919_CR32","doi-asserted-by":"crossref","first-page":"e1001773","DOI":"10.1371\/journal.pmed.1001773","volume":"11","author":"M Laman","year":"2014","unstructured":"Laman M, Moore BR, Benjamin JM, Yadi G, Bona C, Warrel J, et al. Artemisinin\u2013naphthoquine versus artemether\u2013lumefantrine for uncomplicated malaria in Papua New Guinean children: an open-label randomized trial. PLoS Med. 2014;11:e1001773.","journal-title":"PLoS Med"},{"key":"919_CR33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12936-015-0624-4","volume":"14","author":"M Laman","year":"2015","unstructured":"Laman M, Benjamin JM, Moore BR, Salib M, Tawat S, Davis WA, et al. Artemether\u2013lumefantrine versus artemisinin\u2013naphthoquine in Papua New Guinean children with uncomplicated malaria: a six months post-treatment follow-up study. Malar J. 2015;14:121.","journal-title":"Malar J"},{"key":"919_CR34","first-page":"150","volume":"66","author":"E Lesaffre","year":"2008","unstructured":"Lesaffre E. Superiority, equivalence, and non-inferiority trials. Bull NYU Hosp Jt Dis. 2008;66:150\u20134.","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"919_CR35","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1128\/AAC.48.11.4271-4280.2004","volume":"48","author":"K Stepniewska","year":"2004","unstructured":"Stepniewska K, Taylor WR, Mayxay M, Price R, Smithuis F, Guthmann J, et al. In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow-up. Antimicrob Agents Chemother. 2004;48:4271\u201380.","journal-title":"Antimicrob Agents Chemother"},{"key":"919_CR36","volume-title":"Antimalarial drug combination therapy","author":"WHO","year":"2001","unstructured":"WHO. Antimalarial drug combination therapy. Geneva: World Health Organization; 2001."},{"key":"919_CR37","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1475-2875-13-114","volume":"13","author":"J Zwang","year":"2013","unstructured":"Zwang J, Dorsey G, M\u00e5rtensson A, d\u2019Alessandro U, Ndiaye JL, Karema C, et al. Plasmodium falciparum clearance in clinical studies of artesunate\u2013amodiaquine and comparator treatments in sub-Saharan Africa, 1999\u20132009. Malar J. 2013;13:114.","journal-title":"Malar J"},{"key":"919_CR38","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/1475-2875-10-278","volume":"10","author":"NJ White","year":"2012","unstructured":"White NJ. The parasite clearance curve. Malar J. 2012;10:278.","journal-title":"Malar J"},{"key":"919_CR39","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1086\/503051","volume":"193","author":"JT Bousema","year":"2006","unstructured":"Bousema JT, Schneider P, Gouagna LC, Drakeley CJ, Tostmann A, Houben R, et al. Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum. J Infect Dis. 2006;193:1151\u20139.","journal-title":"J Infect Dis"},{"key":"919_CR40","volume-title":"Methods for surveillance of antimalarial drug efficacy","author":"WHO","year":"2009","unstructured":"WHO. Methods for surveillance of antimalarial drug efficacy. Geneva: World Health Organization; 2009."},{"key":"919_CR41","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4269\/ajtmh.2007.77.181","volume":"77","author":"F Nosten","year":"2007","unstructured":"Nosten F, White NJ. Artemisinin-based combination treatment of falciparum malaria. Am J Trop Med Hyg. 2007;77:181\u201392.","journal-title":"Am J Trop Med Hyg"},{"key":"919_CR42","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1111\/j.1538-7836.2011.04507.x","volume":"9","author":"J Beyer-Westendorf","year":"2011","unstructured":"Beyer-Westendorf J, Buller H. External and internal validity of open label or double-blind trials in oral anticoagulation: better, worse or just different? J Thromb Haemost. 2011;9:2153\u20138.","journal-title":"J Thromb Haemost"},{"key":"919_CR43","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4269\/ajtmh.2007.77.153","volume":"77","author":"LS Vestergaard","year":"2007","unstructured":"Vestergaard LS, Ringwald P. Responding to the challenge of antimalarial drug resistance by routine monitoring to update national malaria treatment policies. Am J Trop Med Hyg. 2007;77:153\u20139.","journal-title":"Am J Trop Med Hyg"},{"key":"919_CR44","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1126\/science.1155165","volume":"320","author":"NJ White","year":"2008","unstructured":"White NJ. Qinghaosu (Artemisinin): the price of success. Science. 2008;320:330.","journal-title":"Science"},{"key":"919_CR45","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1098\/rstb.1999.0426","volume":"354","author":"N White","year":"1999","unstructured":"White N. Antimalarial drug resistance and combination chemotherapy. Phil Trans R Soc Lond B. 1999;354:739\u201349.","journal-title":"Phil Trans R Soc Lond B"},{"key":"919_CR46","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1046\/j.1365-2125.1998.00830.x","volume":"46","author":"F Ezzet","year":"1998","unstructured":"Ezzet F, Mull R, Karbwang J. Population pharmacokinetics and therapeutic response of CGP 56697 (artemether\u00a0+\u00a0benflumetol) in malaria patients. Br J Clin Pharmacol. 1998;46:553\u201361.","journal-title":"Br J Clin Pharmacol"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-015-0919-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T07:45:33Z","timestamp":1567237533000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.malariajournal.com\/content\/14\/1\/392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,6]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["919"],"URL":"https:\/\/doi.org\/10.1186\/s12936-015-0919-5","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,6]]},"article-number":"392"}}